These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7580193)

  • 1. Lack of postmenopausal estrogen replacement therapy and the risk of dementia.
    Mortel KF; Meyer JS
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):334-7. PubMed ID: 7580193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of depression with Alzheimer's disease and vascular dementia in an elderly Arab population of Wadi-Ara, Israel.
    Bowirrat A; Oscar-Berman M; Logroscino G
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):246-51. PubMed ID: 16477584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease.
    Mortel KF; Wood S; Pavol MA; Meyer JS; Rexer JL
    Angiology; 1993 Aug; 44(8):599-605. PubMed ID: 8342875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risks and benefits of estrogen replacement therapy: Leisure World.
    Paganini-Hill A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():54-62. PubMed ID: 7581589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective studies of cerebral perfusion and cognitive testing among elderly normal volunteers and patients with ischemic vascular dementia and Alzheimer's disease.
    Mortel KF; Pavol MA; Wood S; Meyer JS; Terayama Y; Rexer JL; Herod B
    Angiology; 1994 Mar; 45(3):171-80. PubMed ID: 8129197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HRT and dementia.
    Skoog I; Gustafson D
    J Epidemiol Biostat; 1999; 4(3):227-51; discussion 252. PubMed ID: 10695961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular dementia prevention: a risk factor analysis.
    Román GC
    Cerebrovasc Dis; 2005; 20 Suppl 2():91-100. PubMed ID: 16327258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports.
    Ohkura T; Isse K; Akazawa K; Hamamoto M; Yaoi Y; Hagino N
    Dementia; 1995; 6(2):99-107. PubMed ID: 7606287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review.
    Zec RF; Trivedi MA
    Neuropsychol Rev; 2002 Jun; 12(2):65-109. PubMed ID: 12371603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Errors produced on the mini-mental state examination and neuropsychological test performance in Alzheimer's disease, ischemic vascular dementia, and Parkinson's disease.
    Jefferson AL; Cosentino SA; Ball SK; Bogdanoff B; Leopold N; Kaplan E; Libon DJ
    J Neuropsychiatry Clin Neurosci; 2002; 14(3):311-20. PubMed ID: 12154156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimate of dementia prevalence in a community sample from São Paulo, Brazil.
    Bottino CM; Azevedo D; Tatsch M; Hototian SR; Moscoso MA; Folquitto J; Scalco AZ; Bazzarella MC; Lopes MA; Litvoc J
    Dement Geriatr Cogn Disord; 2008; 26(4):291-9. PubMed ID: 18843181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of dementia: frequency, causes and clinical profile. A national referral hospital-based study in Oman.
    Shelley BP; Al Khabouri J
    Dement Geriatr Cogn Disord; 2007; 24(4):280-7. PubMed ID: 17717414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types.
    Mortel KF; Meyer JS; Herod B; Thornby J
    Dementia; 1995; 6(1):55-62. PubMed ID: 7728220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future therapeutic developments of estrogen use.
    Fillit H
    J Clin Pharmacol; 1995 Sep; 35(9S):25S-28S. PubMed ID: 8530715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premorbid psychosocial behavior in demented patients.
    Motomura N; Ohkubo F; Tomota Y; Akagi H; Asano A; Seo T
    Int J Neurosci; 1998 Sep; 95(3-4):167-72. PubMed ID: 9777437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging.
    Baldereschi M; Di Carlo A; Lepore V; Bracco L; Maggi S; Grigoletto F; Scarlato G; Amaducci L
    Neurology; 1998 Apr; 50(4):996-1002. PubMed ID: 9566385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial.
    Yaffe K; Krueger K; Cummings SR; Blackwell T; Henderson VW; Sarkar S; Ensrud K; Grady D
    Am J Psychiatry; 2005 Apr; 162(4):683-90. PubMed ID: 15800139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Alzheimer's or vascular dementia be prevented with control of vascular risk factors?
    Goldberg TH; Griffith JP
    W V Med J; 2011; 107(3):20-5. PubMed ID: 21702410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.